In a  published this week in the New England Journal of Medicine, the Centers for Medicare & Medicaid Services and Centers for Disease Control and Prevention highlight a decline in certain patient safety indicators during the COVID-19 pandemic and call for a renewed focus on patient safety going forward.

In a statement today, AHA President and CEO Rick Pollack said, 鈥淢ore than two years into an unprecedented worldwide pandemic, America鈥檚 hospitals and health systems, and our caregivers, remain more dedicated than ever to patient safety and delivering the highest quality of care to all. Our field has made many important gains over the last decade in improving care quality and has been transparent about sharing our progress. 

鈥淟ast September, CDC published data showing decline in hospitals鈥 progress in reducing health care associated infections, such as central line associated blood stream infections (CLABSI), catheter associated urinary tract infections (CAUTI) and methicillin-resistant Staphylococcus aureus (MRSA). This unprecedented virus put incredible stress on hospitals and clearly impeded some efforts to sustain hard-fought gains in making care better and safer. However, hospitals commitment to improving safety is steadfast. 

鈥淭his Call to Action from CMS and CDC demonstrates that their commitment to patient safety is also unwavering. We agree that there are opportunities to create more durable safety improvement strategies, enhance 鈥榡ust in time training鈥 for staff called upon to perform tasks for patients with different needs than those for whom they typically provide care, and innovate to ensure hospitals have strong and diversely skilled teams available to care for all who require care, even during a national emergency.  
 
鈥淲e view this Call to Action as an opportunity to work collaboratively with CMS and CDC and other committed organizations to gain valuable insights and build more resiliency into our patient safety efforts.鈥
 

Related News Articles

Headline
The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to the potential for serious injury鈥
Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump鈥
Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride鈥
Headline
The Food and Drug Administration has identified a Class I recall of Q鈥橝pel Medical 072 Aspiration System after the company submitted three device event reports鈥
Headline
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue鈥
Headline
The AHA Living Learning Network is launching the Quality Exchange, a virtual collaborative for health care quality and patient safety professionals at鈥